Skip to main content
. 2016 Jun 8;16:14. doi: 10.1186/s40644-016-0072-6

Fig. 1.

Fig. 1

Maximum intensity protection (MIP) images of a patient with physiological distribution of 68Ga-PSMA ligand. Accumulation is seen in lacrimal and salivary glands, nasal mucosa, liver, spleen, bowel, kidneys and bladder